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Background
• Weight gain after liver transplantation (LT) is common,
particularly in patients transplanted for NASH cirrhosis,
and is associated with reduced survival.[1]
• While immunosuppressant use is often implicated as a
key driver of post-LT weight gain, published literature
has failed to support this assertion.[2]
• In non-LT patients, presence and sub-optimal
management of depression is closely associated with
weight gain and obesity.[3] The impact of depression as
predictor of post-LT weight gain is currently not known.
• The aim of the present study was to bridge this gap in
knowledge by evaluating the relationship between
depression, liver disease and weight change after LT.
Methods
• All adult patients receiving LT between 7/2007 to
7/2017 were included in the analysis (N= 384). Patients
with graft failure or death within 6 months after LT
were excluded.
• Baseline weight was weight 2 weeks after LT to avoid
contribution of peri-transplant edema.
• All patients meeting criteria were followed every 6
months in clinic where vital sign, weight,
demographics, laboratory, medical history, anti-
depressant use, and psychosocial history was collected.
• Screening for depression was performed by a
psychologist or psychiatrist using DSM-IV/V
guidelines.
Results
Conclusion
• Presence and under-treatment of depression are
associated with more profound weight gain in patients
transplanted for NASH cirrhosis, likely reflecting poor
coping mechanisms.
• Additional trials with aggressive screening and
treatment of depression in patients transplanted for
NASH cirrhosis are essential to mitigate post-LT
weight gain
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CLD, N= 384
NASH, n= 79ETOH, n= 78HCV, n= 227
NASH w/o Depression
NASH with Depression
ETOH with Depression
HCV with Depression
HCV w/o Depression
ETOH w/o Depression
NASH with Depression
Untreated Depression
Treated Depression
HCV ETOH NASH
Age, year 57.4±5.7 54.6±8.6 58.8±7.6
Gender
Male, n (%) 186 (81.9) 60 (76.9) 54 (68.4)
Female 41 (18.1) 18 (23.1) 25 (31.6)
BMI, kg/m2 26.0±5 24.1±4.8 27.9±5.1
Diabetes, n (%) 66 (29.1) 19 (24.4) 47 (59.5)
Hypertension, n (%) 106 (46.7) 43 (55.1) 55 (69.5)
Dyslipidemia, n (%) 24 (11.4) 15 (19.7) 35 (46.1)
Depression, n (%) 60 (30.2) 18 (26.1) 27 (35.5)
Figure 1:
NASH, HCV, and ETOH with Depression vs No Depression
Figure 2:
Treated vs Untreated Depression in NASH Population
